Acalabrutinib
Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Zanubrutinib
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Leukemia & Lymphoma Society
ASH: COVID-19 Resources for Managing Blood Cancers
UpToDate